Download presentation
Presentation is loading. Please wait.
Published byMaria Stewart Modified over 8 years ago
1
USRDS 2000 ADR USRDS Hepatitis B vaccine & antibody among patients & unit staff figure 9.1, dialysis patients, 1997, by network
2
USRDS 2000 ADR USRDS Percent of patients receiving hepatitis B vaccine figure 9.2, dialysis patients, 1997, by HSA Percent of patients
3
USRDS 2000 ADR USRDS Percent of unit staff receiving hepatitis B vaccine figure 9.3, 1997, by HSA Percent of unit staff
4
USRDS 2000 ADR USRDS Hepatitis C diagnosis rates figure 9.4, per 100 patient years at risk, incident & prevalent hemodialysis patients, 1998, by HSA Rate per 100 patient years at risk
5
USRDS 2000 ADR USRDS Hepatitis C diagnosis rates figure 9.5, per 100 patient years at risk, incident & prevalent peritoneal dialysis patients, 1998, by HSA Rate per 100 patient years at risk
6
USRDS 2000 ADR USRDS Hepatitis C diagnosis rates figure 9.6, per 100 patient years at risk, incident & prevalent transplant patients, 1998, by HSA Rate per 100 patient years at risk
7
USRDS 2000 ADR USRDS Breast cancer screening figure 9.7, all ESRD patients
8
USRDS 2000 ADR USRDS Cervical cancer screening figure 9.8, all ESRD patients
9
USRDS 2000 ADR USRDS Prostate cancer screening figure 9.9, all ESRD patients
10
USRDS 2000 ADR USRDS Diabetic eye exams figure 9.10, prevalent diabetic ESRD patients
11
USRDS 2000 ADR USRDS Glycosylated hemoglobin testing figure 9.11, prevalent diabetic ESRD patients
12
USRDS 2000 ADR USRDS Patients receiving influenza vaccine (%) figure 9.12, all ESRD patients, by HSA Percent of patients
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.